• Je něco špatně v tomto záznamu ?

MLPA analysis of 32 foetuses with a congenital heart defect and 1 foetus with renal defects - pilot study. The significant frequency rate of presented pathological CNV

A. Stefekova, P. Capkova, Z. Capkova, V. Curtisova, J. Srovnal, E. Mracka, E. Klaskova, M. Prochazka

. 2022 ; 166 (2) : 187-194. [pub] 20210331

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22014551

AIMS: The aim of this retrospective study was to determine the detection rate of the pathogenic copy number variants (CNVs) in a cohort of 33 foetuses - 32 with CHD (congenital heart defects) and 1 with kidney defect, after exclusion of common aneuploidies (trisomy 13, 18, 21, and monosomy X) by karyotyping, Multiplex ligation - dependent probe amplification (MLPA) and chromosomal microarray analysis (CMA). We also assess the effectivity of MLPA as a method of the first tier for quick and inexpensive detection of mutations, causing congenital malformations in foetuses. METHODS: MLPA with probe mixes P070, P036 - Telomere 3 and 5, P245 - microdeletions, P250 - DiGeorge syndrome, and P311 - CHD (Congenital heart defects) was performed in 33 samples of amniotic fluid and chorionic villi. CMA was performed in 10 relevant cases. RESULTS: Pathogenic CNVs were found in 5 samples: microdeletions in region 22q11.2 (≈2 Mb) in two foetuses, one distal microdeletion of the 22q11.2 region containing genes LZTR1, CRKL, AIFM3 and SNAP29 (≈416 kb) in the foetus with bilateral renal agenesis, 8p23.1 (3.8 Mb) microdeletion syndrome and microdeletion in area 9q34.3 (1.7 Mb, Kleefstra syndrome). MLPA as an initial screening method revealed unambiguously pathogenic CNVs in 15.2 % of samples. CONCLUSION: Our study suggests that MLPA and CMA are a reliable and high-resolution technology and should be used as the first-tier test for prenatal diagnosis of congenital heart disease. Determination of the cause of the abnormality is crucial for genetic counselling and further management of the pregnancy.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22014551
003      
CZ-PrNML
005      
20230629091658.0
007      
ta
008      
220602s2022 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.5507/bp.2021.019 $2 doi
035    __
$a (PubMed)33824538
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Štefeková, Andrea $u Department of Medical Genetics, University Hospital Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $7 xx0303361
245    10
$a MLPA analysis of 32 foetuses with a congenital heart defect and 1 foetus with renal defects - pilot study. The significant frequency rate of presented pathological CNV / $c A. Stefekova, P. Capkova, Z. Capkova, V. Curtisova, J. Srovnal, E. Mracka, E. Klaskova, M. Prochazka
520    9_
$a AIMS: The aim of this retrospective study was to determine the detection rate of the pathogenic copy number variants (CNVs) in a cohort of 33 foetuses - 32 with CHD (congenital heart defects) and 1 with kidney defect, after exclusion of common aneuploidies (trisomy 13, 18, 21, and monosomy X) by karyotyping, Multiplex ligation - dependent probe amplification (MLPA) and chromosomal microarray analysis (CMA). We also assess the effectivity of MLPA as a method of the first tier for quick and inexpensive detection of mutations, causing congenital malformations in foetuses. METHODS: MLPA with probe mixes P070, P036 - Telomere 3 and 5, P245 - microdeletions, P250 - DiGeorge syndrome, and P311 - CHD (Congenital heart defects) was performed in 33 samples of amniotic fluid and chorionic villi. CMA was performed in 10 relevant cases. RESULTS: Pathogenic CNVs were found in 5 samples: microdeletions in region 22q11.2 (≈2 Mb) in two foetuses, one distal microdeletion of the 22q11.2 region containing genes LZTR1, CRKL, AIFM3 and SNAP29 (≈416 kb) in the foetus with bilateral renal agenesis, 8p23.1 (3.8 Mb) microdeletion syndrome and microdeletion in area 9q34.3 (1.7 Mb, Kleefstra syndrome). MLPA as an initial screening method revealed unambiguously pathogenic CNVs in 15.2 % of samples. CONCLUSION: Our study suggests that MLPA and CMA are a reliable and high-resolution technology and should be used as the first-tier test for prenatal diagnosis of congenital heart disease. Determination of the cause of the abnormality is crucial for genetic counselling and further management of the pregnancy.
650    12
$a variabilita počtu kopií segmentů DNA $x genetika $7 D056915
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a plod $7 D005333
650    12
$a vrozené srdeční vady $x diagnóza $x genetika $7 D006330
650    _2
$a lidé $7 D006801
650    _2
$a pilotní projekty $7 D010865
650    _2
$a těhotenství $7 D011247
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a transkripční faktory $x genetika $7 D014157
655    _2
$a časopisecké články $7 D016428
700    1_
$a Čapková, Pavlína, $u Department of Medical Genetics, University Hospital Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $d 1966- $7 xx0046895
700    1_
$a Čapková, Zuzana $u Department of Medical Genetics, University Hospital Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $7 _AN114558
700    1_
$a Curtisová, Václava $u Department of Medical Genetics, University Hospital Olomouc, Czech Republic $7 xx0155864
700    1_
$a Srovnal, Josef $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic $u Department of Pediatrics, University Hospital Olomouc, Czech Republic $7 xx0091239
700    1_
$a Mracká, Enkhjargalan $u Department of Medical Genetics, University Hospital Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $7 xx0303357
700    1_
$a Klásková, Eva $u Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $u Department of Pediatrics, University Hospital Olomouc, Czech Republic $7 xx0081724
700    1_
$a Procházka, Martin, $u Department of Medical Genetics, University Hospital Olomouc, Czech Republic $u Faculty of Medicine and Dentistry, Palacky University Olomouc, Olomouc, Czech Republic $d 1970- $7 xx0019288
773    0_
$w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $x 1213-8118 $g Roč. 166, č. 2 (2022), s. 187-194
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33824538 $y Pubmed
910    __
$a ABA008 $b A 1502 $c 958 $y p $z 0
990    __
$a 20220602 $b ABA008
991    __
$a 20230629091653 $b ABA008
999    __
$a ok $b bmc $g 1824806 $s 1165772
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 166 $c 2 $d 187-194 $e 20210331 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
LZP    __
$b NLK198 $a Pubmed-20220602
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace